8月11日，微创机器人-B盘中上涨6.16%，报24.8港元，成交额9638.0万港元。
消息面上，大华继显首次覆盖公司并给予"买入"评级，目标价29港元，认为公司拥有业内最全面的手术机器人产品组合。同时，公司此前发布盈喜，预计上半年净利润为2800万至4000万元，去年同期亏损1.15亿元，系首次实现半年度盈利；收入同比增长约200%至230%，核心产品图迈机器人海外收入增长超过450%，整体毛利率提升超过15个百分点。海通国际指出，公司扭亏得益于收入增长、毛利率改善与费用管控优化三者共同作用，伴随国内外装机放量，规模效应有望逐步释放。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.